Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Who We Help
  2. Insights
  3. Events
  4. Contact Us
MAIN/search
MAIN/Who We Help
Who We Help/
WHO WE HELP
  • Pharmaceutical Manufacturers
  • Emerging Biopharma
  • MedTech
  • Financial Institutions
  • Government and Public Health
  • Health Plans
  • Hospital and Health Systems
  • Insurers and Risk
  • Medical Specialty and Patient Advocacy
Pharmaceutical Manufacturers

Harness unparalleled healthcare data, advanced analytics, and cutting-edge technologies with our expertise to accelerate the development and commercialization of innovative medicines, enhancing patient lives.

Harness Data
Pharmaceutical Manufacturers
Emerging Biopharma (Global page)

Boost your innovation with IQVIA's expert team. Our comprehensive solutions integrate top-tier insights, technology, and expertise to maximize your asset's success in a competitive landscape.

Discover Innovations
MedTech

Navigating MedTech's unique landscape: U.S. decision-making now rests with GPOs, IDNs, and payers, who demand solid value proof through rigorous outcomes analyses and pricing scrutiny.

Explore MedTech
MedTech
Financial Institutions

Invest in healthcare with confidence. Stay ahead of pharma and medical device trends using real-time, high-quality data. Access market insights, historical sales, prescription trends, and emerging product information for informed, risk-reduced decisions.

Access Insights
Government and Public Health

Unlock deeper health insights with unmatched data and innovative technology to enhance decision-making for your essential government programs.

Unlock Innovations
Government and Public Health
Health Plans

Accelerate digital innovation with our data-driven expertise in data science and healthcare, optimizing business processes for smarter decisions.

Navigate Health Plans
Hospital and Health Systems

Leverage digital innovation to cut costs, boost efficiency, and elevate patient engagement, all while enhancing quality and health outcomes.

Streamline Decisions
Hospital and Health Systems
Insurers and Risk

Enhance your ability to evaluate and forecast population risk swiftly and accurately by integrating unmatched data, expertise, and technology.

Evaluate Risk
Medical Specialty and Patient Advocacy

Transform into a data-driven organization that enhances your specialty and showcases value to your members through digital transformation.

Enhance Your Specialty
MAIN/Insights
Insights/
U.S. PROGRESS POINT

A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.

LEARN MORE
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS

PODCASTS

"Discover the future through our enlightening podcasts available in the United States.

EXPLORE PODCASTS

FACT SHEET

"IQVIA AI Medical Record Review

LEARN MORE

BLOG

"Decoding DSCSA: Ensuring Compliance in the Pharmaceutical Supply Chain

READ MORE
MAIN/Events
Events/
ON-DEMAND WEBINARS

Visit our library of on-demand webinars.

WATCH ON-DEMAND WEBINARS
UPCOMING EVENTS & WEBINARS

View our upcoming events and webinars.

DISCOVER EVENTS & WEBINARS

EVENT

"26th Controlled Substances and State Regulatory Conference

REGISTER NOW
MAIN/Contact Us
Contact Us/
Blog
A Foreword — Their Finest Hour: Medical Affairs in a Disrupted World
From the U.S. Progress Point Editorial Board
Aug 30, 2023

The evolution of a single function or role is not often remarkable or newsworthy: Organizations shift to meet the needs of customers and challenges of the market; technology or information renders the status quo inefficient, and revised processes and measurements are put in place; changing behavior and preference demands new talent or expertise. But sometimes a changing function is a signal, or even a proxy, of a much larger shift.

COVID-19 left an indelible mark on healthcare, sometimes instigating and sometimes accelerating transformation everywhere. Healthcare professionals (HCPs) have reset both needs and expectations in what information they get and from whom. Patients have increased their involvement and agency, and healthcare systems continue to recover from financial burden. Each of these dynamics has created an unprecedented premium on value and evidence: Understanding what works, for whom, and how well is now mandatory.

But to meet that new mandate, pharmaceutical organizations need to (among other things) look inside and re-think the role that Medical Affairs plays — not just as a third pillar alongside R&D and Commercial, but as now a mission-critical bridge between the two. Moving this team to center stage, as the quarterback of information and expertise, will strengthen the flow of evidence and information, optimize HCP decision-making, and add a critical layer of support around medicines that are increasingly complex.

Read more about IQVIA’s perspective on this new collaboration model, the importance of redefining value, and the demand for alignment between pharma, HCPs, and healthcare systems to improve performance and achieve optimal health outcomes.

Progress is not an individual activity — it is the fruit of collective thinking and collaborative debate. In that spirit, Progress Point publishes both original work and critical thinking from across the IQVIA organization. The paper referenced in this article was originally published on September 16, 2022, and has been re-published for the benefit of our U.S. Progress Point viewers.

U.S. Progress Point Subscribers' Circle: First-looks, exclusive content, and more.
Subscribe
Contact Us